Treatment of androgenetic alopecia: current guidance and unmet needs
M Kaiser, R Abdin, SI Gaumond, NT Issa… - Clinical, Cosmetic and …, 2023 - Taylor & Francis
Androgenetic alopecia (AGA) is the most common cause of hair loss in men and women.
Traditionally, topical minoxidil and oral finasteride have been the standard of care yielding …
Traditionally, topical minoxidil and oral finasteride have been the standard of care yielding …
The efficacy and safety of oral and topical spironolactone in androgenetic alopecia treatment: a systematic review
C Wang, Y Du, L Bi, X Lin, M Zhao… - Clinical, Cosmetic and …, 2023 - Taylor & Francis
Introduction Androgenetic alopecia (AGA) has negative impacts on both men and women in
terms of appearance and mental stress. Spironolactone is a synthetic aldosterone receptor …
terms of appearance and mental stress. Spironolactone is a synthetic aldosterone receptor …
[PDF][PDF] Role of Spironolactone in the Treatment of Female Patterns Hair Loss With Polycystic Ovarian Syndrome
MD Mahmood, MM Merkhan - ON RESEARCH IN, 2023 - researchgate.net
Hair loss is a common progressive continuous condition affecting both males and females
with limited availability of effective therapy. The following study aimed to evaluate the …
with limited availability of effective therapy. The following study aimed to evaluate the …